Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -8.79%17.72B | -5.25%77.52B | -6.41%57.57B | -11.47%38.08B | -4.74%19.42B | -17.30%81.82B | -16.78%61.51B | -12.19%43.01B | -10.31%20.39B | -3.15%98.94B |
| Operating income | -8.79%17.72B | -5.25%77.52B | -6.41%57.57B | -11.47%38.08B | -4.74%19.42B | -17.30%81.82B | -16.78%61.51B | -12.19%43.01B | -10.31%20.39B | -3.15%98.94B |
| Operating expenses | 9.16%-17.17B | 11.12%-73.41B | 11.48%-54.64B | 14.69%-36.24B | 5.82%-18.9B | 15.12%-82.59B | 15.53%-61.73B | 14.21%-42.48B | 11.63%-20.07B | 1.56%-97.31B |
| Gross profit | 4.68%549.72M | 631.20%4.12B | 1,468.28%2.93B | 250.08%1.83B | 62.25%525.15M | -147.54%-774.78M | -125.41%-214.23M | 196.32%523.02M | 1,065.62%323.66M | -50.72%1.63B |
| Selling expenses | 6.48%-63.59M | -0.79%-306.03M | 0.74%-206.64M | 4.55%-137.8M | 10.26%-68M | 11.02%-303.64M | 21.53%-208.18M | 18.85%-144.37M | -13.12%-75.77M | -15.62%-341.24M |
| Administrative expenses | -12.78%-239.67M | -10.29%-961.8M | -4.62%-682.78M | -0.57%-437.31M | -4.52%-212.51M | 6.57%-872.04M | 0.29%-652.66M | 4.72%-434.83M | -14.77%-203.33M | 26.14%-933.38M |
| Research and development expenses | 37.57%-130.19M | 3.74%-1.06B | -0.48%-784.36M | -7.79%-549.32M | 8.46%-208.52M | 10.39%-1.1B | 14.62%-780.58M | 20.79%-509.63M | 14.91%-227.79M | -5.46%-1.23B |
| Profit from asset sales | 1,778,585.18%102.71M | 82.38%-47.65M | -145.75%-33.65M | -84.51%11.39M | -100.01%-5.78K | -388.05%-270.37M | 241.45%73.55M | 335.51%73.53M | 258.20%60.46M | -78.68%93.86M |
| Revaluation surplus | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 93.23%-1.6M | -214.91%-34.56M |
| -Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 93.23%-1.6M | -214.91%-34.56M |
| Impairment and provision | 349.18%26M | -4.12%-939.72M | -6.75%-359.05M | -3.28%-347.94M | -414.46%-10.43M | 5.38%-902.53M | 47.16%-336.35M | 46.62%-336.89M | -93.14%3.32M | 37.48%-953.86M |
| -Other impairment is provision | 349.18%26M | -4.12%-939.72M | -6.75%-359.05M | -3.28%-347.94M | -414.46%-10.43M | 5.38%-902.53M | 47.16%-336.35M | 46.62%-336.89M | -93.14%3.32M | 37.48%-953.86M |
| Special items of operating profit | -65.93%48.95M | -44.69%288.21M | 9.33%354.77M | 7.04%232.72M | -4.39%143.65M | -49.04%521.05M | -38.82%324.48M | -56.90%217.41M | 101.01%150.24M | 3.59%1.02B |
| Operating profit | 265.19%184.44M | 113.36%557.09M | 139.45%847.83M | 141.39%358.22M | 147.80%50.5M | -270.02%-4.17B | -50.59%-2.15B | 60.37%-865.37M | 77.21%-105.66M | -3,273.72%-1.13B |
| Financing income | 70.00%44.22M | 9.66%109.02M | 8.98%82.15M | 45.55%66.94M | 13.57%26.01M | 61.53%99.42M | 66.70%75.38M | 143.98%45.99M | 127.10%22.91M | 33.39%61.55M |
| Financing cost | 36.01%-88.79M | 21.50%-466.2M | 11.64%-409.19M | 8.50%-285.56M | 6.69%-138.76M | -17.22%-593.92M | -24.83%-463.12M | -34.73%-312.07M | -40.19%-148.7M | -7.15%-506.68M |
| Special items of earning before tax | -198.02%-9.73M | 91.75%-8.94M | 114.44%1.41M | 158.28%5.12M | 362.05%9.93M | -3,664.47%-108.35M | -514.70%-9.79M | -791.08%-8.78M | -479.91%-3.79M | 96.25%-2.88M |
| Earning before tax | 284.50%119.97M | 102.90%140.06M | 118.43%483.69M | 109.89%117.71M | 75.42%-65.03M | -202.50%-4.83B | -50.52%-2.62B | 49.57%-1.19B | 50.98%-264.51M | -184.80%-1.6B |
| After-tax profit from continuing operations | 190.72%97.24M | 99.45%-27.2M | 112.89%355.92M | 103.07%40.22M | -107.19M | -203.90%-4.98B | -49.68%-2.76B | 46.09%-1.31B | 0 | -100.17%-1.64B |
| After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---345.64M | ---- |
| Earning after tax | 190.72%97.24M | 99.45%-27.2M | 112.89%355.92M | 103.07%40.22M | 68.99%-107.19M | -203.90%-4.98B | -49.68%-2.76B | 46.09%-1.31B | 40.76%-345.64M | -100.17%-1.64B |
| Minority profit | 48.75%54.87M | 155.97%181.6M | 220.39%272.3M | 168.81%115M | 206.50%36.89M | -3.75%-324.45M | 8.37%-226.17M | 15.55%-167.12M | 53.30%-34.64M | -915.01%-312.74M |
| Profit attributable to shareholders | 129.40%42.37M | 95.52%-208.81M | 103.30%83.63M | 93.47%-74.78M | 53.67%-144.08M | -251.06%-4.66B | -58.64%-2.53B | 48.79%-1.14B | 38.93%-311M | -54.75%-1.33B |
| Basic earnings per share | 150.00%0.01 | 95.08%-0.03 | 103.31%0.0109 | 93.28%-0.01 | 50.00%-0.02 | -258.82%-0.61 | -58.65%-0.3292 | 48.58%-0.1487 | 42.86%-0.04 | -47.83%-0.17 |
| Diluted earnings per share | 150.00%0.01 | 95.08%-0.03 | 103.31%0.0109 | 93.28%-0.01 | 50.00%-0.02 | -258.82%-0.61 | -58.65%-0.3292 | 48.58%-0.1487 | 42.86%-0.04 | -47.83%-0.17 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Accounting Firm (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.